Samarium-153-ethylene diamine tetramethylene phosphonate, a beta-emitting bone-targeted radiopharmaceutical, useful for patients with osteoblastic bone metastases

Longo J, Lutz S, Johnstone C

Cancer Management and Research 2013, 5:235-242

Published Date: 13 August 2013